NASDAQ:MMSI - Nasdaq - US5898891040 - Common Stock - Currency: USD
92.9
-0.87 (-0.93%)
The current stock price of MMSI is 92.9 USD. In the past month the price decreased by -5.3%. In the past year, price increased by 13%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ALC | ALCON INC | 28.29 | 42.41B | ||
COO | COOPER COS INC/THE | 17.72 | 13.75B | ||
ALGN | ALIGN TECHNOLOGY INC | 18.77 | 12.70B | ||
SOLV | SOLVENTUM CORP | 12.23 | 12.59B | ||
LNTH | LANTHEUS HOLDINGS INC | 11.77 | 5.39B | ||
BLCO | BAUSCH + LOMB CORP | 24.13 | 4.09B | ||
HAE | HAEMONETICS CORP/MASS | 15.1 | 3.32B | ||
ICUI | ICU MEDICAL INC | 18.62 | 3.20B | ||
XRAY | DENTSPLY SIRONA INC | 9.15 | 3.06B | ||
UFPT | UFP TECHNOLOGIES INC | 28.86 | 1.82B | ||
NEOG | NEOGEN CORP | 13.89 | 1.15B | ||
ESTA | ESTABLISHMENT LABS HOLDINGS | N/A | 1.08B |
Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. The company is headquartered in South Jordan, Utah and currently employs 7,400 full-time employees. Its segments include cardiovascular and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer (OEM). Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in various clinical areas, such as radiology, electrophysiology, and more.
MERIT MEDICAL SYSTEMS INC
1600 West Merit Park Way
South Jordan UTAH 84095 US
CEO: Fred P. Lampropoulos
Employees: 7400
Phone: 18012531600
The current stock price of MMSI is 92.9 USD. The price decreased by -0.93% in the last trading session.
The exchange symbol of MERIT MEDICAL SYSTEMS INC is MMSI and it is listed on the Nasdaq exchange.
MMSI stock is listed on the Nasdaq exchange.
17 analysts have analysed MMSI and the average price target is 111.08 USD. This implies a price increase of 19.57% is expected in the next year compared to the current price of 92.9. Check the MERIT MEDICAL SYSTEMS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
MERIT MEDICAL SYSTEMS INC (MMSI) has a market capitalization of 5.49B USD. This makes MMSI a Mid Cap stock.
MERIT MEDICAL SYSTEMS INC (MMSI) currently has 7400 employees.
MERIT MEDICAL SYSTEMS INC (MMSI) has a support level at 92.87 and a resistance level at 93.27. Check the full technical report for a detailed analysis of MMSI support and resistance levels.
The Revenue of MERIT MEDICAL SYSTEMS INC (MMSI) is expected to grow by 9.78% in the next year. Check the estimates tab for more information on the MMSI EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
MMSI does not pay a dividend.
MERIT MEDICAL SYSTEMS INC (MMSI) will report earnings on 2025-07-30, after the market close.
The PE ratio for MERIT MEDICAL SYSTEMS INC (MMSI) is 26.02. This is based on the reported non-GAAP earnings per share of 3.57 and the current share price of 92.9 USD. Check the full fundamental report for a full analysis of the valuation metrics for MMSI.
The outstanding short interest for MERIT MEDICAL SYSTEMS INC (MMSI) is 5.91% of its float. Check the ownership tab for more information on the MMSI short interest.
ChartMill assigns a technical rating of 2 / 10 to MMSI. When comparing the yearly performance of all stocks, MMSI turns out to be only a medium performer in the overall market: it outperformed 51.95% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to MMSI. While MMSI has a great profitability rating, there are some minor concerns on its financial health.
Over the last trailing twelve months MMSI reported a non-GAAP Earnings per Share(EPS) of 3.57. The EPS increased by 13.69% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 8.81% | ||
ROA | 4.95% | ||
ROE | 8.56% | ||
Debt/Equity | 0.51 |
ChartMill assigns a Buy % Consensus number of 85% to MMSI. The Buy consensus is the average rating of analysts ratings from 17 analysts.
For the next year, analysts expect an EPS growth of -1.9% and a revenue growth 9.78% for MMSI